Risk Communication Advisory Committee
This article was originally published in The Tan Sheet
FDA is requesting nominations for membership to its new advisory committee. Comprising 15 voting members, the committee will advise the agency on ways to better communicate the risks and benefits of FDA-regulated products. FDA formed the advisory group in response to recommendations by the Institute of Medicine's 2006 report, "The Future of Drug Safety: Promoting and Protecting the Health of the Public"...
You may also be interested in...
FDA is modifying the charter for its Risk Communication Advisory Committee to reflect new powers the agency gained as part of the passed FDA reauthorization bill
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.